Patents

US 12551533 B2: Intranasal neuropeptides for use in stress-related impairments

Granted
2026-02-17
Filed
2020-03-18 application 17440445
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Intranasal neuropeptide Y (NPY) analogs having D-amino acids, such as [D26-His]-NPY are provided for early intervention to prevent or to treat, to reverse, or reduce symptoms of stress-related impairments such as PTSD, depression, substance abuse, and/or memory deficits following exposure to traumatic or surgical stress.

Source: PTBLXML, file of 2026-02-17 (ipgb20260217.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
NEW YORK MEDICAL COLLEGE 19 patentsUS company or organizationValhalla, NYNew York Medical College College or university EXACT high confidence: identical full name and state
NEW YORK MEDICAL COLLEGE Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-02-17

Inventors

InventorPlacePatentsPerson pageSource
Esther L. SabbanBronx, NYPTBLXML, file of 2026-02-17

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/2271PTBLXML, file of 2026-02-17

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.